ArticleCancer research2010

Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma.

Ian J Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.